What is Gemelli Biotech?
Gemelli Biotech is a specialty biotechnology company dedicated to advancing human health through microbiome research. The company's core mission involves unlocking the potential of the microbiome to discover novel diagnostics and therapeutics. By focusing on bringing biotechnology innovations to market in a fiscally responsible and socially conscious manner, Gemelli Biotech aims to foster a global family of healthy individuals. Their work in this rapidly evolving field positions them at the forefront of personalized medicine and diagnostic advancements.
How much funding has Gemelli Biotech raised?
Gemelli Biotech has raised a total of $19M across 1 funding round:
Series A
$19M
Series A (2022): $19M with participation from Cerracap Ventures, Cedars-Sinai, Blue Ox Healthcare Partners, and Carolina Angel Network
Key Investors in Gemelli Biotech
Cerracap Ventures
Cerracap Ventures is a venture capital firm that focuses on industrializing innovation by investing in early-stage companies across various sectors, providing strategic guidance and resources to scale their businesses.
Cedars-Sinai
Cedars-Sinai is a non-profit academic medical center with clinical programs ranging from primary care to specialized treatments for rare and complex illnesses, serving the community through its Medical Network.
Blue Ox Healthcare Partners
Blue Ox Healthcare Partners is a commercial-stage growth investor focused on precision health and individualized medicine, seeking to invest in technology-enabled innovations that improve healthcare delivery and affordability.
What's next for Gemelli Biotech?
The recent major strategic investment in Gemelli Biotech signals a pivotal moment for the company, likely enabling accelerated development of its diagnostic and therapeutic pipelines. This capital infusion is expected to fuel expansion, further research into microbiome-based solutions, and potentially broaden market reach. The company's focus on innovation within the biotechnology space, coupled with its commitment to responsible development, positions it for significant advancements in addressing complex health challenges.
See full Gemelli Biotech company page
